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vCardiogenic  shock  (CS)  is  deﬁned  as  persistent  hypotension
(systolic  blood  pressure  <90  mmHg)  secondary  to  myocardial
dysfunction,  associated  with  signs  of  organ  hypoperfusion.
CS  may  be  present  in  10%  of  patients  with  ST-segment  ele-
vation  myocardial  infarction  (STEMI)  and  is  associated  with
30-day  mortality  of  about  50%.1 In  the  majority  of  STEMI
patients,  hemodynamic  deterioration  occurs  after  hospital
admission,  which  means  that  there  may  be  room  for  pre-
ventive  measures  and  highlights  the  importance  of  early
recognition  of  those  most  likely  to  evolve  to  CS.2
Scores  such  as  Controlled  Abciximab  and  Device  Investi-
gation  to  Lower  Late  Angioplasty  Complications  (CADILLAC),
Thrombolysis  in  Myocardial  Infarction  (TIMI),  the  Global  Reg-
istry  of  Acute  Coronary  Events  (GRACE)  and  the  Zwolle  risk
score  are  used  to  stratify  patients  and  enable  the  adoption  of
different  levels  of  clinical  monitoring,  therapeutic  care  and
post-discharge  strategies.3,4 However,  the  search  for  simpler
and  more  accurate  scores  has  continued.
The  shock  index  (SI)  is  deﬁned  as  the  ratio  of  heart
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olemia  in  hemorrhagic  or  infectious  shock  states.5 The
I,  which  is  easy  to  calculate,  is  an  objective  measure  of
ardiovascular  performance  and  a marker  for  predicting
he  onset  of  hypotension.  Assessment  of  SI  in  the  con-
ext  of  acute  myocardial  infarction  was  only  used  more
ecently,  and  a  ﬁrst  meta-analysis,  of  eight  studies  enrolling
0  404  patients,  was  published  last  year.6 A  high  SI  was  asso-
iated  with  increased  in-hospital  mortality  and  higher  risk  of
hort-  and  long-term  adverse  outcomes  compared  to  low  SI.
An  important  limitation  of  SI  is  the  lack  of  informa-
ion  about  systemic  vascular  resistance  status.  Mean  arterial
ressure  (incorporating  both  systolic  and  diastolic  blood
ressure)  best  represents  tissue  perfusion  status.  The  mod-
ﬁed  shock  index  (MSI),  which  is  the  ratio  of  heart  rate
o  mean  arterial  pressure,  has  been  shown  to  be  a  bet-
er  predictor  of  mortality  than  heart  rate,  systolic  blood
ressure,  diastolic  blood  pressure  and  SI  alone  in  trauma
atients.7
Shangguan  et  al.  were  the  ﬁrst  to  assess  the  predictive
alue  of  MSI  in  the  context  of  STEMI.8 In  a retrospective
tudy  of  160  consecutive  patients,  they  found  that  MSI  ≥1.4,
ssessed  in  the  emergency  department,  was  an  independent
actor  for  major  adverse  cardiac  events  and  seven-day  all-
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ause  mortality,  with  a  stronger  association  than  SI.  Yu  et  al.
etrospectively  studied  1864  STEMI  patients  undergoing  pri-
ary  coronary  angioplasty  to  assess  whether  admission
ge  SI  (age  multiplied  by  SI)  and  MSI  were  useful  clinical
arameters  to  predict  long-term  prognosis,  with  both  show-
ng  good  prognostic  performance.9 The  cutoff  value  of  MSI
or  the  prediction  of  all-cause  mortality  was  0.71.
In  this  issue  of  the  Journal,  Abreu  et  al.10 assess  the  prog-
ostic  value  of  MSI  to  predict  six-month  mortality  in  a  large
etrospective  observational  study  of  1158  STEMI  patients
ithout  cardiogenic  shock  on  admission.  They  found  that  MSI
0.93  was  present  in  about  a  quarter  of  the  patients  and  was
ssociated  with  worse  in-hospital  clinical  course.  Adverse
vents,  acute  heart  failure  and  cardiogenic  shock  were  sig-
iﬁcantly  more  frequent  in  this  subgroup.  MSI  was  also  an
ndependent  predictor  of  overall  six-month  mortality.  The
utoff  of  0.93  identiﬁed  by  the  authors  is  between  those
n  the  above  studies,  which  presumably  reﬂects  method-
logical  differences,  such  as  population  selection  and  the
iming  and  method  for  assessing  hemodynamic  parameters.
owever,  their  approach  of  using  MSI  in  patients  with  no
hock  at  admission,  and  assessing  heart  rate  and  blood  pres-
ure  in  the  hemodynamic  laboratory,  seems  to  be  the  most
ppropriate  and  practical  way  to  apply  this  index  in  clinical
ractice.
Their  study  has  limitations,  some  of  which  are  acknowl-
dged  by  the  authors,  including  its  single-center  and
etrospective  design,  the  lack  of  a  control  group  to  effec-
ively  test  their  hypothesis,  and  the  lack  of  comparison  with
ther  hemodynamic  indices  or  risk  scores.  Nevertheless,  the
uthors  should  be  congratulated  for  their  important  contri-
ution  to  an  issue  that  is  still  poorly  deﬁned  and  that  needs
urther  investigation,  since  a  simple  risk  stratiﬁcation  of
hese  patients  remains  an  unmet  clinical  need.  They  have
aved  the  way  for  future  studies  that  may  validate  this
trategy.onﬂicts of interest
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